CM
NMRA icon

Caption Management’s Neumora Therapeutics NMRA Stock Holding History

Caption Management’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
609,500
-10,500
-2% -$20K ﹤0.01% 1125
2026
Q1 		$1.21M Buy
+620,000
New +$1.61M 0.01% 958
2025
Q1 		– Sell
-633,300
Closed -$6.71M – 1868
2024
Q4 		$6.71M Buy
+633,300
New +$7.59M 0.06% 286

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caption Management's NMRA Position: Q2 2026 in Review

Caption Management reduced its Neumora Therapeutics (NMRA) stake by 24% in Q2 2026, selling an estimated $188K and leaving 313,217 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Caption Management first reported a position in NMRA in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.11M in Q4 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Caption Management held 313,217 shares of Neumora Therapeutics worth $532K as of Q2 2026.
  • Caption Management sold 98,984 Neumora Therapeutics shares in Q2 2026, an estimated $188K.
  • Neumora Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1304 holding.
  • Caption Management first reported a position in Neumora Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Caption Management's Neumora Therapeutics position peaked at $1.11M in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.